tiprankstipranks
Trending News
More News >
Innate Pharma SA (FR:IPH)
:IPH

Innate Pharma SA (IPH) Revenue

Compare
6 Followers

Innate Pharma SA Revenue

Innate Pharma SA had a revenue of 4.33M in the quarter ending Dec 31, 2024, with -64.93%. This bring the company's revenue in the last twelve months to 16.67M, Increased -50.65%. In the fiscal year ending Dec 31, 2024, Innate Pharma SA had annual revenue of 12.62M with -75.68% growth.
Revenue (ttm)
16.67M
Revenue Growth
P/S Ratio
14.05
Revenue/Employee
$69,735
Employees
181
Market Cap
$177.31M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202412.62M-39.28M-75.68%
Dec 31, 202351.90M2.26M+4.56%
Dec 31, 202249.64M37.53M+309.83%
Dec 31, 202112.11M-57.66M-82.64%
Dec 31, 202069.77M800.00K+1.16%
Dec 31, 201968.97M-10.92M-13.67%
Dec 31, 201879.89M47.26M+144.83%
Dec 31, 201732.63M-23.53M-41.90%
Dec 31, 201656.16M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis